an overview of the neomonarch trial in hr /her2- breast cancer
Published 7 years ago • 255 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
2:06
response to abemaciclib in the neomonarch trial
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
1:36
an overview of the meribel study in her2-negative breast cancer
-
7:52
introduction and overview of her2-targeted therapies in breast cancer
-
4:39
neomonarch: cdk inhibition for hr positive, her negative breast cancer
-
4:01
dual her2 blockade in early breast cancer
-
18:32
usmle ace video 261: breast pathologies - common benign disorders and malignant tumors
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
2:00
dr. hurvitz on neomonarch trial for hr breast cancer
-
1:16:56
navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer
-
0:59
dr. varella on the results of monaleesa-7 in hr /her2- breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:59
an overview of a phase ii study of ont-380 in her2-positive breast cancer
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy